|
CN104478766A
|
|
Method for preparing high-purity acetyl homotaurine
|
|
CN104546778A
|
|
Medical composition of Gliclazide sustained release preparation and preparation method of medical composition
|
|
CN104473907A
|
|
Tacrolimusoral sustained-release preparation
|
|
CN104586792A
|
|
Lansoprazole enteric-coated preparation
|
|
CN104546817A
|
|
Pregabalin sustained release preparation
|
|
CN104478856A
|
|
Purificationmethod of esomeprazole magnesiumkey intermediate
|
|
CN104473882A
|
|
Mecobalamin granules
|
|
CN103936714A
|
|
Preparation method of esomeprazole magnesium
|
|
CN103690504A
|
|
Method for preparing rosuvastatin calcium tablet solid dispersion
|
|
CN103690508A
|
|
Tablet composition containing pitavastatin calcium and preparation method of tablet
|
|
CN103694175A
|
|
New method for preparing dexmedetomidine hydrochloride
|
|
CN103784414A
|
|
Esomeprazole enteric-coated tablets and preparation method thereof
|
|
CN103788073A
|
|
Novel method for preparing voriconazole key intermediate
|
|
CN103664861A
|
|
Novel method for preparing olopatadine hydrochloride by using high-activity organic zinc reagent
|
|
CN103655497A
|
|
Montelukast orally disintegrating tablet and preparation method thereof
|
|
CN103690498A
|
|
Preparation method capable of improving stability of repaglinide tablets
|
|
CN103694228A
|
|
New method of pitavastatin calcium key intermediate
|
|
CN103044401A
|
|
Preparation method of benzimidazole compound
|
|
CN103044400A
|
|
Esomeprazole magnesium salt and preparation method thereof
|
|
CN103058996A
|
|
Nitrogen heterocyclic compound preparation method and application thereof
|
